|
TVIS20016445
|
Human Papillomavirus |
HPV16 |
- |
2601 |
- |
hg19 |
chr20 |
33710037 |
33710037 |
q11.22 |
PXMP4 |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |
|
TVIS20016446
|
Human Papillomavirus |
HPV16 |
- |
225 |
- |
hg19 |
chr20 |
33714674 |
33714674 |
q11.22 |
PXMP4 |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |
|
TVIS20016447
|
Human Papillomavirus |
HPV16 |
- |
879 |
- |
hg19 |
chr20 |
33706900 |
33706900 |
q11.22 |
PXMP4 |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |
|
TVIS20016448
|
Human Papillomavirus |
HPV16 |
- |
1301 |
- |
hg19 |
chr20 |
33706900 |
33706900 |
q11.22 |
PXMP4 |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |
|
TVIS20016449
|
Human Papillomavirus |
HPV16 |
- |
3356 |
- |
hg19 |
chr20 |
33706901 |
33706901 |
q11.22 |
PXMP4 |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |
|
TVIS20016450
|
Human Papillomavirus |
HPV16 |
- |
3392 |
- |
hg19 |
chr20 |
33707383 |
33707383 |
q11.22 |
PXMP4 |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |
|
TVIS20016451
|
Human Papillomavirus |
HPV16 |
- |
3361 |
- |
hg19 |
chr20 |
33707384 |
33707384 |
q11.22 |
PXMP4 |
Tumor |
Cervical cancer |
RNA sequencing, followed by integration sites detection using ChimeraScan, deFuse and SOAPFuse |
33785400 |
2021 |
Curated |
|
TVIS30017406
|
Human Immunodeficiency Virus |
HIV-1 type B |
- |
- |
- |
hg19 |
chr20 |
34192908 |
34192928 |
q11.22 |
ENSG00000303127 |
Tumor |
- |
Non-restrictive linear amplification-mediated PCR (nrLAM-PCR), followed by InStAP analysis |
33784259 |
2021 |
Curated |
|
TVIS30017439
|
Human Immunodeficiency Virus |
HIV-1 type B |
- |
- |
- |
hg19 |
chr20 |
410481 |
410556 |
p13 |
RBCK1 |
Tumor |
- |
Non-restrictive linear amplification-mediated PCR (nrLAM-PCR), followed by InStAP analysis |
33784259 |
2021 |
Curated |
|
TVIS30017440
|
Human Immunodeficiency Virus |
HIV-1 type B |
- |
- |
- |
hg19 |
chr20 |
36997362 |
36997442 |
q11.23 |
RBL1 |
Tumor |
- |
Non-restrictive linear amplification-mediated PCR (nrLAM-PCR), followed by InStAP analysis |
33784259 |
2021 |
Curated |